Market revenue in 2023 | USD 13.9 million |
Market revenue in 2030 | USD 204.4 million |
Growth rate | 46.9% (CAGR from 2023 to 2030) |
Largest segment | Drug discovery & development |
Fastest growing segment | Drug Discovery & Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery & Development, Precision Medicine, Diagnotics |
Key market players worldwide | International Business Machines Corp, Microsoft Corp, NVIDIA Corp, Freenome, Thermo Fisher Scientific Inc, Illumina Inc, Sophia Genetics SA, Benevolent AI, Deep Genomics, Data4Cure, Fabric Genomics (formerly Omicia) |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai in genomics market will help companies and investors design strategic landscapes.
Drug discovery & development was the largest segment with a revenue share of 33.81% in 2023. Horizon Databook has segmented the South Korea ai in genomics market based on drug discovery & development, precision medicine, diagnotics covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea ai in genomics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea ai in genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account